05:18 AM EDT, 08/29/2024 (MT Newswires) -- BioCardia ( BCDA ) said late Wednesday that the US Food and Drug Administration cleared the company to market its Morph DNA Steerable Introducer product family.

The company said the clearance is subject to the general controls provisions of the Federal Food, Drug and Cosmetic Act.

Shares of the company soared 114% in Thursday's premarket activity.

Price: 4.7100, Change: +2.51, Percent Change: +114.09